At HLTH21 in October, we sat down with Sheeza Hussain, the Chief Commercial Officer of Biofourmis, to discuss the future of virtual care and her experience with taking hospital-at-home and remote patient monitoring to the next level. Utilizing their FDA-approved  software as a medical device (SaMD) in combination with remote patient monitoring (RPM) data from [practically] any device, their predictive analytics add a layer of reliability and robustness to current virtual and home care models. Throughout this discussion, Sheeza's passion for improving the quality of life for patients through these new tools shines through, and it's easy to see why she was just added to the Becker's list of Women in Health IT to Watch in 2022.

Previously a software engineer, she comes into her role of CCO as someone with a knowledge of both the software and the user sides of the business, working with providers, physicians, and potential partners to maximize Biofourmis’ impact. We spoke with her about her goals for their platform, as well as the specifics of their comprehensive solution, from devices to demographics and from software to support. You can also watch this interview on the Chilmark website here.

Connect with Sheeza: https://www.linkedin.com/in/sheezahussain/
Biofourmis: https://biofourmis.com/technology/

Connect with us:
ChilmarkResearch.com
Send us a message: https://go.chilmarkresearch.com/contact

Follow us on social media:
https://twitter.com/ChilmarkHIT
https://www.linkedin.com/company/chilmark-research/

Video and podcast content produced by Elizabeth Hughes, Ricardo Celis, and John Moore III
Audio production by Colin Rogers